We have developed the most efficient approach for RNA-seq library synthesis.
RNA sequencing is vital for cutting-edge cancer diagnostics, pharmaceutical development, and food security, but the time and cost are major bottlenecks. At Amaryllis Nucleics, our technology breaks down these barriers by cutting time and cost manyfold — empowering researchers and accelerating important discoveries in genomics.
-
RT @carolyn_chlebek: Looking to use #RNAseq in your #orthoresearch? Check out this nice review written by @ORSsociety members summarizin… https://t.co/ozydMaNpLN
-
Thank you OGC! The Oakland Genomics Center and it’s collaborative environment was a great place to grow and was cri… https://t.co/Fn0DzNMTsJ
-
We are excited to be a part of the Active Motif team and to bring our RNA-seq technology to a larger audience!! https://t.co/o7m5MJOGQb
-
RT @activemotif: Active Motif Incorporated Announces the Acquisition of Amaryllis Nucleics and their proprietary RNASeq workflow, wh… https://t.co/ioctzsKk7r
-
RT @ErinSparksPhD: @Margare41291282 We used @AmaryllisNuc and it was great! It’s 3’ so less reads needed overall. Highly recommend for DEG analysis.